Peakhale Sf 50 Mcg/250 Mcg Respicap

Peakhale Sf 50 Mcg/250 Mcg Respicap is used for preventing and controlling asthma symptoms and chronic obstructive pulmonary disease symptoms. These symptoms include shortness of breath, coughing, wheezing and chest tightness. It prevents breathing difficulties during exercise.

Common side effects of Peakhale Sf 50 Mcg/250 Mcg Respicap are sinus infection, dizziness and migraine headaches. In most cases, these side effects are minor and don't require treatment. Certain side effects, however, are serious and should be reported to a healthcare provider immediately. Some of these are high blood pressure, rapid heart rate and worsening of breathing problems.

Use alternate medicines and avoid this medicine if you are allergic to it, using other medicines like long-acting beta-agonist medicine, azole anti-fungal or macrolide antibiotic. This medicine needs to be taken with extra precautions if you have asthma and have frequent asthma attacks.

Peakhale Sf 50 Mcg/250 Mcg Respicap is available as a dry powder inhaler that releases a powdered form of the drug. Your dosage will be determined by the doctor based on your medical condition. If you miss a dose use the medication as soon as you remember, then wait 12 hours before using the medication again. Skip the missed dose if it is almost time for your next scheduled dose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

• Severe Allergic Reaction

• Allergic Disorders

• Asthma

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

• Electrolyte Imbalance

• Redistribution/Accumulation Of Body Fat

• Bone Degradation

• Increased Risk Of Infection

• Muscle Disorders

• Increased Blood Pressure

• Altered Bone Growth

• Skin Scar

• Behavioural Changes

• Increased Glucose Level In Blood

• Cataract

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Combitide 50mcg/100mcg octacap may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Peakhale Sf 50 Mcg/250 Mcg Respicap , and hence can be used as its substitute.

• Fluticure 50 Mcg/250 Mcg Respicap

  Emcure Pharmaceuticals Ltd

• Forair 50 Mcg/250 Mcg Respicap

  Zydus Cadila

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

This medicine acts as a long-acting beta-2 adrenergic agonist. It works by stimulating the intracellular enzyme called adenylyl cyclase, which initiates the process of transformation of adenosine triphosphate (ATP) to cyclic 3’,5’-adenosine monophosphate (AMP). This relaxes bronchial smooth muscle and inhibits the release of immediate hypersensitivity mediators from mast cells.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Pulmonologist before using this medicine.

• Fluticasone Propionate-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 9 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/fluticasone%20propionate

• Fluticasone Propionate-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 9 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00588

• FLUTICASONE PROPIONATE tablet,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 9 June 2022].Available from:

  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=FLUTICASONE+PROPIONATE